Renin-angiotensin system inhibition in advanced chronic kidney disease


eMediNexus    30 January 2023


This investigation suggests that discontinuing RAS inhibitors does not cause significant between-group discrepancies in the long-term rate of decrease in the eGFR among patients with advanced and progressive chronic kidney disease.


Reference- Bhandari S, Mehta S, Khwaja A, et al. Renin–Angiotensin System Inhibition in Advanced Chronic Kidney Disease. New England Journal of Medicine. 2022;387(22):2021-2032. https://www.nejm.org/doi/full/10.1056/NEJMoa2210639

To comment on this article,
create a free account.

Sign Up to instantly get access to 10000+ Articles & 1000+ Cases

Already registered?

Login Now

Most Popular Articles

News and Updates

eMediNexus provides latest updates on medical news, medical case studies from India. In-depth medical case studies and research designed for doctors and healthcare professionals.